Suchergebnisse - (Person:"Sheng, Jifang")

PubPharm (4)

1

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b : a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

enthalten in: BMC gastroenterology | 2019

von Sun, J. | Ding, H. | Chen, G. | +21

2

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

enthalten in: Virology journal | 2016

von Yang, S. | Xing, H. | Wang, Y. | +27

3

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

enthalten in: Gut | 2016

von Fan, R. | Sun, J. | Yuan, Q. | +29

4

Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B : a randomized trial

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2014

von Cheng, J. | Wang, Y. | Hou, J. | +26

1
[1]